iSpeechPathology.com – Call us: 800-242-5183
eLuma - Love What You Do - September 2025

Drug-Induced Dysphagia

Amber B. Heape, CScD, CCC-SLP, FNAP

March 7, 2018

Share:

Question

How do medications increase the likelihood of dysphagia?

 

Answer

Medications have a major potential for influencing dysphagia. Almost any medication could have some type of side effect, whether it is impairing consciousness, coordination, sensory function, motor function, or lubrication and peristalsis of the upper aerodigestive tract.

It is not unusual for older adults or individuals with complex medical conditions to be taking multiple medications which can increase the likelihood of drug-induced dysphagia.  Certainly, medications affect each person differently. Their effects can be influenced by gender, age, physical body size of the patient, the patient's metabolic status at the time, other medications compounded on one another - polypharmaceutical side effects – as well as each individual person and his or her response. If two individuals take the same medication, even if they are the same gender, the same age, and around the same body size, that medication may affect them differently. 

Factors to consider when looking at drug-induced dysphagia are dysphagia due to side effects, dysphagia due to the drug therapy itself, and potential esophageal injury. 

Dysphagia due to side effects.  The more medications a patient takes, the more polypharmaceutical side effects are possible.  One medicine causes a side effect, and then the patient is prescribed another medicine to combat the side effect, but that causes yet another side effect. We get into a “hamster running on the wheel” mode because we are trying to treat one disease or one condition, but the side effects of that treatment cause other conditions.

Xerostomia, or dry mouth, can be caused by allergy medications (antihistamines), medications for depression, angiotensin converting enzyme (ACE) inhibitors, medications for nausea, medications for blood pressure with diuretics in them, cholesterol medications, etc. Medications may also cause decreased taste, or patients may complain of losing their appetites.  Medications may increase constipation and then the patient is given another medication to remedy the constipation.  Metabolic issues related to how those medications are absorbed can also be a factor. Antipsychotics, which are all too common in patients with dementia, may cause dyskinesias (muscle movement disorders) and when a person has a movement disorder there is an increased likelihood of dysphagia.

Dysphagia due to the drug therapy itself.  This is the second factor that can lead to dysphagia. Xerostomia can fall into this category also.  Radiation and chemotherapy increase the likelihood of dysphagia, and may also damage the mucosa. If there is damage to the mucosa, that is absolutely going to lead to an increased probability of dysphagia.  Individuals who may have had transplants, or are on immunosuppressants or even sometimes antibiotics, may get viral or fungal infections.  Thrush in the mouth is a very painful fungal infection.  Typically, a mouthwash is given to combat the infection.  Unfortunately, the taste of the mouthwash is terrible.  Think about patients who have viral or fungal infections, and how those are going to lead to decreased PO intake and the potential for dysphagia.

High-dose corticosteroids, such as prednisone and those types of medications, may lead to muscle wasting. Usually, the muscle wasting does not affect the swallow, but it may. Younger people have to be cautioned when they are on a high dose of corticosteroids, because exercise or physical activity could potentially lead to some injury. Our patients may not be doing high impact exercise or physical activity, but the muscle wasting could have an effect on them as well.

Narcotic pain medications and muscle relaxers can cause decreased muscle control and decreased awareness due to the depression of the central nervous system. Anti-anxiety drugs such as benzodiazepines can also cause a depressed central nervous system. They are used for anxiety, but they do not just lessen the physical anxiety. They depress the nervous system functions, and thus can increase the risk for dysphagia. Anti-psychotics and neuroleptics can cause movement disorders or dyskinesias. Antibiotics can also cause esophogitis, glossitis, or fungal infections.

Esophageal injury.  Esophageal injury is the third factor to consider. Patients take medication orally and then perhaps lie down too quickly or do not drink enough with the medication. The primary peristaltic wave has not moved that medication all the way down through the esophagus and into the stomach, so the medications remain in the esophagus for a longer period of time and can cause irritation and potential for esophageal injury. Aspirin, iron, potassium, vitamin C, and non-steroidal anti-inflammatory drugs (NSAIDs) are all common medications that can cause irritation and some injury if they remain in the esophagus.

Again, medications can have a major impact on swallowing. It is important to think about patients that are currently on your caseload and the influence that multiple medications can have on swallowing function and how they can increase the likelihood of drug-induced dysphagia.  

Please refer to the SpeechPathology.com course, Dysphagia in Patients with Dementia: What's the SLP to Do? - Part 1, for more in-depth information on the common deficits in stages of cognitive decline and the difference between normal versus disordered swallowing.


amber b heape

Amber B. Heape, CScD, CCC-SLP, FNAP

Amber Heape, CScD, CCC-SLP, FNAP, is an Assistant Professor and Director of the Health Professions Education Track in the SLPD program at Rocky Mountain University. Dr. Heape also teaches adult medical coursework at South Carolina State University. She serves in multiple volunteer committees at the state and national levels. She is a Fellow of the National Academies of Practice, a Certified Dementia Practitioner, and teaches interdisciplinary/multidisciplinary courses related to healthcare in the geriatric population.  She is also Coordinator for SIG 15 (Gerontology) and an ASHA Leadership Development Porgram graduate.  Dr. Heape has a passion for clinical education and mentoring future leaders. 


Related Courses

Social Isolation and COVID-19 Cognitive Decline: From Zero to Hero!
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Video

Presenter

Amber B. Heape, CScD, CCC-SLP, FNAP
Course: #9514Level: Intermediate1 Hour
  'Slow rate of speaker’s speech'   Read Reviews
Social distancing and isolation associated with the COVID-10 pandemic have begun to take a toll on patients in residential settings, but SLPs can help mitigate the long-term consequences. This course discusses the risk factors for and effects of isolation, as well as potential strategies to prevent or reverse pandemic-related cognitive decline.

Dysphagia MythBusters: Tackling the Truths About Patient Choice in Residential Care Settings
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Video

Presenter

Amber B. Heape, CScD, CCC-SLP, FNAP
Course: #10077Level: Intermediate1 Hour
  'Great content with excellent organization and presentation'   Read Reviews
Are your residential care patients with dysphagia “non-compliant” with their diets? This course provides a deep dive into a patient-centered approach to dysphagia care that also supports safety. Myths and facts surrounding patient choice are identified, and appropriate courses of action for the SLP are discussed.

Using the Yale Swallow Protocol as a Screening Tool in Residential Care Settings
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Video

Presenter

Amber B. Heape, CScD, CCC-SLP, FNAP
Course: #10863Level: Introductory1 Hour
  'Demonstration of Yale screening'   Read Reviews
SLPs in residential care settings need an evidence-based tool to use for dysphagia screening. This course teaches clinicians differences between screenings and assessments, how to effectively use the Yale Swallow Protocol as a predictive tool, and its relationship to Minimum Data Set (MDS) Assessment.

Rebuilding the Bridge: Post-Pandemic Mentorship for Future SLPs
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Live WebinarTue, Dec 16, 2025 at 3:00 pm EST
Tue, Dec 16, 2025 at 3:00 pm EST

Presenter

Amber B. Heape, CScD, CCC-SLP, FNAP
Course: #11278Level: Intermediate1 Hour
The COVID-19 pandemic disrupted traditional clinical training pathways, leaving many Clinical Fellows and graduate students entering the field with unique challenges and gaps in experience. This course discusses equipping seasoned SLPs with practical, evidence-based strategies to mentor, support, and empower the next generation of clinicians. The course explores real-world scenarios and actionable tools to rebuild confidence, competence, and connection in a post-pandemic professional landscape.

Ethical Practice in Aging Care
Presented by Amber B. Heape, CScD, CCC-SLP, FNAP
Video

Presenter

Amber B. Heape, CScD, CCC-SLP, FNAP
Course: #8755Level: Introductory1 Hour
  'Presentation of case studies to better understand the content'   Read Reviews
As healthcare and reimbursement are changing, therapists often find themselves facing questions of ethics when working with clients who are aging. This course will review the principles of bioethics and how they apply to SLPs working with aging adults. Decision-making scenarios will be presented and discussed for application of knowledge.